Rekombinanter ITGAL (Efalizumab Biosimilar) Antikörper
Reaktivität: Human
BR, FACS
Wirt: Human
Monoclonal
hu1124
unconjugated
Recombinant Antibody
1 image
-
- Target Alle ITGAL (Efalizumab Biosimilar) Produkte
- ITGAL (Efalizumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
-
Human
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser ITGAL (Efalizumab Biosimilar) Antikörper ist unkonjugiert
- Applikation
- Blocking Reagent (BR), Flow Cytometry (FACS)
- Spezifität
- Binds to human LFA-1.
- Produktmerkmale
-
OriginalSpeciesName: Human
OriginalFormat: IgG1
- Aufreinigung
- Purified antibody.
- Reinheit
- > 98 % as determined by SDS-PAGE
- Endotoxin-Niveau
- Endotoxin is < 1.0 EU/mg as determined by the LAL method
- Immunogen
- Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.
- Klon
- Hu1124
- Isotyp
- IgG1 kappa
-
anti-ITGAL (Efalizumab Biosimilar) antibody
Reaktivität: Human BR, FACS Wirt: Kaninchen Monoclonal hu1124 unconjugated Recombinant Antibody
-
- Applikationshinweise
- Efalizumab binds to the LFA-1 alpha I domain blocking the ICAM-1 binding site via steric hindrance.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Target
- ITGAL (Efalizumab Biosimilar)
- Abstract
- ITGAL (Efalizumab Biosimilar) Produkte
- Synonyme
- CD11A antikoerper, LFA-1 antikoerper, LFA1A antikoerper, integrin subunit alpha L antikoerper, ITGAL antikoerper
- Substanzklasse
- Biosimilar
- Hintergrund
- LFA-1, integrin alpha L
- UniProt
- P20701
-
Sie sind hier:
